Prayle D, Brazier M
Institute of Medicine, Law and Bioethics, University of Manchester.
J Med Ethics. 1998 Apr;24(2):93-8. doi: 10.1136/jme.24.2.93.
Radical changes are taking place in the United Kingdom in relation to the classification of, and access to, medicines. More and more medicines are being made available over the counter both in local pharmacies and in supermarkets. The provision of more open access to medicines may be hailed as a triumph for patient autonomy. This paper examines whether such a claim is real or illusory. It explores the ethical and legal implications of deregulating medicines. Do patients benefit? What is the impact on pharmacists? Are the true beneficiaries of change largely the pharmaceutical industries?
在英国,药品的分类和获取方式正在发生根本性变化。越来越多的药品在当地药店和超市都可以非处方购买。提供更开放的药品获取渠道可能被誉为患者自主权的胜利。本文探讨这种说法是真实的还是虚幻的。它探讨了药品管制放松的伦理和法律影响。患者是否受益?对药剂师有什么影响?变革的真正受益者主要是制药行业吗?